Articles dans des revues avec comité de lecture (73)
  1. 8. Bel Lassen, P., Kyrilli, A., Lytrivi, M., & Corvilain, B. (2019). Maladie de Basedow, goitres multinodulaires et hyperthyroïdie infra-clinique. Annales d'Endocrinologie. doi:10.1016/j.ando.2018.09.004
  2. 9. Ghaddhab, C., Kyrilli, A., Driessens, N., Van Den Eeckhaute, E., Hancisse, O., De Deken, X., Dumont, J. E., Detours, V., Miot, F., & Corvilain, B. (2019). Factors contributing to the resistance of the thyrocyte to hydrogen peroxide. Molecular and cellular endocrinology, 481, 62-70. doi:10.1016/j.mce.2018.11.010
  3. 10. Kyrilli, A., Lytrivi, M., Bouquegneau, M. S., Demetter, P., Lucidi, V., Garcia, C., Moreno Reyes, M. R., Tabarin, A., Corvilain, B., & Driessens, N. (2019). Unilateral adrenalectomy could be a valid option for primary nodular adrenal disease: Evidence from twins. Journal of the Endocrine Society, 3(1), 129-134. doi:10.1210/js.2018-00261
  4. 11. Corvilain, B., Hamy, A., Brunaud, L., Borson-Chazot, F., Orgiazzi, J., Bensalem Hachmi, L., Semrouni, M., Rodien, P., & Lussey-Lepoutre, C. (2018). Traitement de la maladie de Basedow de l'adulte. Annales d'Endocrinologie, 79(6), 618-635. doi:10.1016/j.ando.2018.08.003
  5. 12. Kyrilli, A., Lytrivi, M., Bel Lassen, P., & Corvilain, B. (2018). Treatment options of subclinical hyperthyroidism and cardiovascular risk. Current Opinion in Endocrine and Metabolic Research, 2, 38-45. doi:10.1016/j.coemr.2018.01.008
  6. 13. Kyrilli, A., Paternot, S., Miot, F., Corvilain, B., Vassart, G., Roger, P. P., & Dumont, J. E. (2017). Commentary: Under appropriate conditions thyrotropin, through cyclic AMP, directly stimulates human thyrocytes proliferation in vivo and in vitro.: comment on 'Thyrotropin Stimulates Differentiation Not Proliferation of Normal Human Thyrocytes in Culture'. Frontiers in endocrinology, 8, 214. doi:10.3389/fendo.2017.00214
  7. 14. Bel Lassen, P., Kyrilli, A., Lytrivi, M., Ruiz Patino, M. J., & Corvilain, B. (2017). Total thyroidectomy: a clue to understanding the metabolic changes induced by subclinical hyperthyroidism? Clinical endocrinology, 86(2), 270-277. doi:10.1111/cen.13237
  8. 15. Potorac, I., Devuyst, F., Corvilain, B., et al. (2016). T2-weighted MRI signal predicts hormone and tumor responses to somatostatin analogs in acromegaly. Endocrine-related cancer, 23(11), 871-881. doi:10.1530/ERC-16-0356
  9. 16. Eskalli, Z., Achouri, Y., Hahn, S., Many, M.-C., Craps, J., Refetoff, S., Liao, X. H., Dumont, J. E., Van Sande, J., Corvilain, B., Miot, F., & De Deken, X. (2016). Overexpression of Interleukin-4 in the Thyroid of Transgenic Mice Upregulates the Expression of Duox1 and the Anion Transporter Pendrin. Thyroid, 26(10), 1499-1512. doi:10.1089/thy.2016.0106
  10. 17. Lytrivi, M., Kyrilli, A., Burniat, A., Ruiz Patino, M. J., Sokolow, Y., & Corvilain, B. (2016). Thyroid lobectomy is an effective option for unilateral benign nodular disease. Clinical endocrinology, 85(4), 602-608. doi:10.1111/cen.13088
  11. 18. Crenier, L., Lytrivi, M., Van Dalem, A., Keymeulen, B., & Corvilain, B. (2016). Glucose complexity estimates insulin resistance in either nondiabetic individuals or in type 1 diabetes. The Journal of clinical endocrinology and metabolism, 101(4), 1490-1497. doi:10.1210/jc.2015-4035
  12. 19. Corvilain, B., Moreno Reyes, M. R., Kyrilli, A., Lytrivi, M., Bourmorck, C., & Chami, R. (2016). Is there still a role for thyroid scintigraphy in the workup of a thyroid nodule in the era of fine needle aspiration cytology and molecular testing? F1000Research, 5, 763. doi:10.12688/f1000research.7880.1
    13. << Précédent 1 2 3 4 5 6 7 8 9 10 Suivant >>